BAT's New VUSE E-Cigarette Products Enhancing Market Influence

BAT by 2FIRSTS.ai
Dec.24.2024
BAT's New VUSE E-Cigarette Products Enhancing Market Influence
BAT's VUSE announces new e-cigarette series to strengthen market influence, including "VUSE GO BOX 6ml" and "VUSE GO SLIM 2ml.

According to a report from N.News on December 24th, British American Tobacco Korea (referred to as "BAT") announced that its e-cigarette brand VUSE plans to launch three new series to enhance its market influence.


VUSE has recently launched two new products, "VUSE GO BOX 6ml" and "VUSE GO SLIM 2ml." With these new releases, VUSE now offers a total of three different forms, including the "VUSE GO 2ml," with a total of 16 different flavors, making a total of 20 product combinations available.


The "VUSE GO SLIM 2ml" comes in six different flavors and is currently available in the four districts of Mapo, Gangnam, Seocho, and Songpa in Seoul. There are plans to gradually expand the sales area.


The "VUSE GO BOX 6ml" has triple the capacity of the original "VUSE GO 2ml" and is priced at 25,000 Korean Won (17 USD). It comes in four flavors: Cold Fresh, Purple Fresh, Pullet Fresh, and Green Spark.


The company stated that they are continuously strengthening their brand image through the "VUSE GO 2ml", and also expanding their market competitiveness through the "VUSE GO BOX 6ml" and "VUSE GO SLIM 2ml".


Officials from BAT stated that VUSE is leading a major transformation in the e-cigarette market with innovative products. They plan to expand smoke-free options while maintaining high quality and convenience in order to provide consumers with a richer experience in the future.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris and R.J. Reynolds Face Trial Over Woman’s Lung Cancer Death in Massachusetts
Philip Morris and R.J. Reynolds Face Trial Over Woman’s Lung Cancer Death in Massachusetts
According to Law360, the family of Maria Petruzziello has taken Philip Morris and R.J. Reynolds to trial in Massachusetts, alleging the companies are responsible for her 2019 lung cancer death after decades of smoking. Plaintiffs argue her experience mirrors many smokers, while the defense points to her years-long cessation and personal choice.
Dec.03 by 2FIRSTS.ai
Tajikistan Signals Plan to Ban Use, Production and Circulation of E-Cigarettes
Tajikistan Signals Plan to Ban Use, Production and Circulation of E-Cigarettes
According to Kazinform, Tajikistan addressed the issue of electronic cigarettes during the fourth session of the Majlisi Milli, stating a position to prohibit the use, production, and circulation of e-cigarettes. Chairman Rustam Emomali emphasized that the position aims to protect public health and prevent negative impacts on youth and adolescents.
Dec.16 by 2FIRSTS.ai
German Environment Minister Backs Ban on Disposable E-Cigarettes, Citing Safety Risks
German Environment Minister Backs Ban on Disposable E-Cigarettes, Citing Safety Risks
Germany’s Environment Minister Carsten Schneider has expressed clear support for banning disposable e-cigarettes, citing safety hazards, environmental damage, and waste management risks. While the ban has not yet been finalized, Germany’s parliament has instructed the government to examine the proposal. Several European countries, including Belgium, France, and the UK, have already implemented similar bans.
Dec.30 by 2FIRSTS.ai
ZYN Rolls Out “X-Low” Campaign in the UK to Target Low-Strength Nicotine Pouch Market
ZYN Rolls Out “X-Low” Campaign in the UK to Target Low-Strength Nicotine Pouch Market
Philip Morris International’s (PMI) nicotine pouch brand ZYN has launched an “X-Low” low-strength campaign in the UK, accelerating its push into the ultra-low nicotine pouch segment, with updated packaging and new flavours already rolled out in both the UK and the Philippines.
Dec.09 by 2FIRSTS.ai
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Altria on December 19 confirmed that six on! PLUS nicotine pouch products had received U.S. FDA marketing authorization, ending a PMTA review lasting more than a year after the company moved ahead with launch plans before clearance.
Regulations
Dec.20
2Firsts’ Nine Global Turning Points: How 2025 Reshaped the Nicotine Industry
2Firsts’ Nine Global Turning Points: How 2025 Reshaped the Nicotine Industry
In 2025, the global nicotine industry reached a critical turning point. Regulatory realignment, category shifts, capital repositioning and technological intervention unfolded in parallel, loosening old structures while new ones took shape. 2Firsts reviews nine pivotal events that reshaped the industry’s trajectory.
Jan.14